Population pharmacogenomics of CYP1A2, CYP2C19, CYP2D6 and CYP3A4 in a Uruguayan cohort with schizophrenia

Biomedicine & Pharmacotherapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles